UiPath, Inc.: Form 10-Q for the period ended Oct 31, 2023
Filed with the SEC on Dec 4, 2023 and accepted by EDGAR at Dec 4, 2023, 17:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-08-01 to 2023-10-31 | $325.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-02-01 to 2023-10-31 | $902.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-08-01 to 2023-10-31 | $49.9m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-02-01 to 2023-10-31 | $142.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-08-01 to 2023-10-31 | $276.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-02-01 to 2023-10-31 | $760.2m | us-gaap:GrossProfit |
| Research and development | 3 months2023-08-01 to 2023-10-31 | $84.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-02-01 to 2023-10-31 | $246.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-08-01 to 2023-10-31 | −$55.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-02-01 to 2023-10-31 | −$179.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-08-01 to 2023-10-31 | $3.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-02-01 to 2023-10-31 | $11.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-08-01 to 2023-10-31 | −$31.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-02-01 to 2023-10-31 | −$123.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-08-01 to 2023-10-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-02-01 to 2023-10-31 | −$0.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-08-01 to 2023-10-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-02-01 to 2023-10-31 | −$0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-08-01 to 2023-10-31 | 567,036,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-02-01 to 2023-10-31 | 562,651,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-02-01 to 2023-10-31 | $153.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-02-01 to 2023-10-31 | $3.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-02-01 to 2023-10-31 | $52.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-10-31 | $1.00bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-10-31 | $2.43bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-10-31 | $2.79bn | us-gaap:Assets |
| Current liabilities | At period end2023-10-31 | $627.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-10-31 | $825.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-10-31 | $1.96bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001734722-23-000065. Last ingested by Listed: Oct 26, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.